Search

Author/Creator Korn, Stephanie

4. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10056 (29th October 2016)

Authors:
FitzGerald, J Mark; Bleecker, Eugene R; Nair, Parameswaran; Korn, Stephanie; Ohta, Ken; Lommatzsch, Marek; Ferguson, Gary T; Busse, William W; Barker, Peter; Sproule, Stephanie; Gilmartin, Geoffrey; Werkström, Viktoria; Aurivillius, Magnus; Goldman, Mitchell
Journal:
Lancet
Issue:
Volume 388:Issue 10056(2016)
Page Start:
2128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Characteristics and treatment regimens across ERS SHARP severe asthma registries. Issue 1 (9th January 2020)

Authors:
van Bragt, Job J.M.H.; Adcock, Ian M.; Bel, Elisabeth H.D.; Braunstahl, Gert-Jan; ten Brinke, Anneke; Busby, John; Canonica, Giorgio W.; Cao, Hui; Chung, Kian Fan; Csoma, Zsuzsanna; Dahlén, Barbro; Davin, Elizabeth; Hansen, Susanne; Heffler, Enrico; Horvath, Ildiko; Korn, Stephanie; Kots, Maxim; ...
Other Names:
author non-byline.; Abenhardt B. author non-byline.; Adcock I.M. author non-byline.; Adler J. author non-byline.; Alfonso R. author non-byline.; Ali R. author non-byline.; Alkameh S. author non-byline.; Almonacid Sánchez C. author non-byline.; Alvares L. author non-byline.; Anderson G. author no...
Journal:
European respiratory journal
Issue:
Volume 55:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793]. (May 2022)

Authors:
Korn, Stephanie; Milger, Katrin; Skowasch, Dirk; Timmermann, Hartmut; Taube, Christian; Idzko, Marco; Voß, Hans Werner; Holtdirk, Annette; Hamelmann, Eckard; Buhl, Roland
Journal:
Respiratory medicine
Issue:
Volume 196(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022)

Authors:
Montgomery, Hugh; Hobbs, F D Richard; Padilla, Francisco; Arbetter, Douglas; Templeton, Alison; Seegobin, Seth; Kim, Kenneth; Campos, Jesus Abraham Simón; Arends, Rosalinda H; Brodek, Bryan H; Brooks, Dennis; Garbes, Pedro; Jimenez, Julieta; Koh, Gavin C K W; Padilla, Kelly W; Streicher, Katie; V...
Journal:
Lancet
Issue:
Volume 10:Issue 10(2022)
Page Start:
985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Issue 9 (September 2015)

Authors:
Brightling, Christopher E; Chanez, Pascal; Leigh, Richard; O'Byrne, Paul M; Korn, Stephanie; She, Dewei; May, Richard D; Streicher, Katie; Ranade, Koustubh; Piper, Edward
Journal:
Lancet
Issue:
Volume 3:Issue 9(2015)
Page Start:
692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Issue 9 (September 2015)

Authors:
Brightling, Christopher E; Chanez, Pascal; Leigh, Richard; O'Byrne, Paul M; Korn, Stephanie; She, Dewei; May, Richard D; Streicher, Katie; Ranade, Koustubh; Piper, Edward
Journal:
Lancet
Issue:
Volume 3:Issue 9(2015)
Page Start:
692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study. Issue 7 (July 2022)

Authors:
Wechsler, Michael E; Menzies-Gow, Andrew; Brightling, Christopher E; Kuna, Piotr; Korn, Stephanie; Welte, Tobias; Griffiths, Janet M; Sałapa, Kinga; Hellqvist, Åsa; Almqvist, Gun; Lal, Harbans; Kaur, Primal; Skärby, Tor; Colice, Gene; Cambursano, Victor H; Fernandez, Marcelo J; Scherbovsky, Ferna...
Journal:
Lancet
Issue:
Volume 10:Issue 7(2022)
Page Start:
650
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗